Navigation Links
New drug combination brings 1-2 punch against acute leukemia
Date:5/16/2008

CINCINNATI, OHIO - Researchers at The University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation.

In a preclinical study, Lauren Akers, D.O., postdoctoral fellow from the Children's Cancer Hospital at M. D. Anderson, found that combining a novel glycolysis inhibitor, 3-BrOP, with mTOR inhibitor, rapamycin, induced more than 90 percent cell death in human tissue cultures of acute lymphocytic leukemia. She presented her study at the American Society of Pediatric Hematology/Oncology annual conference on May 16.

"We already knew that 3-BrOP was effective in preclinical research of glioblastoma, colon cancer and lymphoma, and most recently acute leukemias" says Akers, lead investigator on the study. "We also knew that mTOR inhibitors intensify cellular starvation. This study showed that the two together have a more powerful impact on treating acute lymphocytic leukemia, which is the most common childhood cancer."

Glycolysis is a process that turns glucose into energy for cells. Unlike healthy cells that get their energy for growth from both glycolysis and respiration, cancer cells are highly dependent on glycolysis. Using the M. D. Anderson-developed drug, 3-BrOP, researchers inhibited glycolysis, thus starving the leukemia cells from their energy source while leaving healthy cells free to get their energy from respiration.

Rapamycin is an mTOR inhibitor that keeps cancer cells from coping with stress, thus resulting in cell death. When researchers on the study combined the two drugs, they discovered a synergistic effect.

"We found that a lower dosage of 3-BrOP with rapamycin created the same results of more than 90 percent tumor cell death," says Akers. "Theoretically, we believe that patients will better tolerate the therapy by lowering the dosage of 3-BrOP and combining it with rapamycin."

Other researchers on the study include senior investigator Patrick Zweidler-McKay, M.D., Ph.D., Anna Franklin, M.D. and Wendy Fang, M.D., all from the Children's Cancer Hospital at M. D. Anderson. Peng Huang, M.D., Ph.D., from the Department of Molecular Pathology at M. D. Anderson was also an investigator and was responsible for the development of 3-BrOP.

The team of researchers plans to conduct additional mouse studies, which could lead to a Phase I clinical trial some time in the future.


'/>"/>

Contact: Sara Farris
sfarris@mdanderson.org
281-467-1337
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Combination therapy reverses effects of portal hypertension in rats
3. Combination vaccines okay for infants, study shows
4. Antidepressants and painkillers - a dangerous combination
5. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Drug combination might offer hope for patients deadly brain tumors
8. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
9. Combination targets: some drugs may work best when they work together
10. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New drug combination brings 1-2 punch against acute leukemia
(Date:5/22/2017)... ... May 22, 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” ... with Bipolar 1. Donald Rodriguez takes readers on a rollercoaster ride that includes a ... of winter and to a dark place where Donald considers suicide. Readers learn ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, the ... in InsightRX, an early stage company in San Francisco that has developed software ... Greatpoint Ventures Innovation Fund acted as the lead investor in the round. ...
(Date:5/21/2017)... Viejo, CA (PRWEB) , ... May 20, 2017 ... ... self-animating, paragraph styled corporate text designs created specifically for use in Final Cut ... editing process for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 years United Cutlery has ... knives and swords, from functional to fantasy. United Cutlery has always been “Stronger. Sharper” ... that defy tradition. , Offering a range of weapons and tools built for battle, ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader ... of Charlotte recently began recruitment efforts for the inaugural cohort of its ... skills, knowledge and expertise to approach and address the unique nuances healthcare organizations ...
Breaking Medicine News(10 mins):
(Date:5/12/2017)...  The China and Canada joint tech ... water, energy and detergent, and features a powerful disinfection process. ... washing machine that washes and sanitizes women,s panties or babies, cloth ... ... does not require an external water inlet. ...
(Date:5/10/2017)... MIAMI , May 10, 2017 Global ... in Latin America , published its 2017 ... The ranking is based on extensive data analysis from GHI,s ... world,s largest hospitals database for the region. The GHI database ... , offering more than 130 data points for each ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
Breaking Medicine Technology: